Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
CRITICAL RISK
Score updated Aug 28, 2026

SNTI — Senti Biosciences Holdings, Inc. Dilution Risk Tracker

Track SNTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNTI — Get alerts when the score changes →

As of August 28, 2026, Senti Biosciences Holdings, Inc. (SNTI) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. Senti Biosciences Holdings, Inc. has a market capitalization of $29.64M, 31.14M shares outstanding, 16 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $6.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 60%
💰 Capital Raise model 73%
• Critical: only 1.6 months cash remaining
• Active ATM program with $6M remaining capacity
🔄 Reverse Split model est. 70%
• 50-day avg $0.95 below $1 exchange minimum
• Only 2 months cash — financial pressure
📉 Score Deterioration model 15%
• Score already CRITICAL (81/100) — events likely imminent
🔔 Track SNTI — Get forecast alerts →

Market Data

Market Cap$29.64M
Shares Outstanding31.14M
Float14.43M
Cash$6.46M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 9.8% shares (2026Q1 vs prior)
16 institutional holders · 6.17M shares
#1 NEA Management Company, LLC 3.78M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 1.08M shares
#3 Nantahala Capital Management, LLC 888.0K shares
+ 13 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest580.4K
Days to Cover1.7
% of Float4.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
424B5 ATM 2026-05-01
8-K 8K EVENT 2026-05-01
EFFECT EFFECT 2026-04-29
EFFECT EFFECT 2026-04-29
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SNTI Dilution Snapshot

Senti Biosciences Holdings, Inc. (SNTI) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SNTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SNTI
SNTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.